Charcot-Marie-Tooth – Waisman Center – UW–Madison

Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B

Niacin ameliorates Charcot-Marie-Tooth 4B1 neuropathy without interfering with nerve regeneration

The role of ATP citrate lyase in myelin formation and maintenance

Peripheral Nervous System (PNS) Myelin Diseases

Post-transcriptional microRNA repression of PMP22 dose in severe Charcot-Marie-Tooth disease type 1

Modulation of Schwann cell homeostasis by the BAP1 deubiquitinase

A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism. Human molecular genetics, ddac170

ACTL6a coordinates axonal caliber recognition and myelination in the peripheral nerve

MicroRNAs as Biomarkers of Charcot-Marie-Tooth Disease Type 1A

Revisiting the pathogenic mechanism of the GJB1 5′ UTR c.-103C > T mutation causing CMTX1